Depot medroxyprogesterone acetate and epithelial ovarian cancer: A multicentre case-control study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 6, 2012, Pages 672-677

  Wilailak, S ^a   Vipupinyo, C ^b   Suraseranivong, V ^c   Chotivanich, K ^d   Kietpeerakool, C ^e   Tanapat, Y ^f   Therasakvichya, S ^g   Hamontri, S ^h   Linasmita, V ^a   Bunyapipat, S ⁱ   Chindavijak, S ^j   Ittiwisavakul, K ^k   Khemapech, N ^l   Suekwattana, P ^m   Thanapprapasr, D ^a   Lumbiganon, P ⁿ  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

^c Bhumipol Hospital   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Faculty of Medicine Chiang Mai University   (Thailand)

^f PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h SRINAKHARINWIROT UNIVERSITY   (Thailand)

ⁱ PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^j NATIONAL CANCER INSTITUTE   (Thailand)

^k Maharat Nakhon Si Thammarat Hospital   (Thailand)

^l CHULALONGKORN UNIVERSITY   (Thailand)

^m NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

ⁿ KHON KAEN UNIVERSITY   (Thailand)

more..

Author keywords

Depot medroxyprogesterone acetate; epithelial ovarian cancer

Indexed keywords

MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST FEEDING; BRENNER TUMOR; CANCER RISK; CARCINOSARCOMA; CASE CONTROL STUDY; CLEAR CELL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FAMILY HISTORY; GYNECOLOGIC CANCER; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; THAILAND; TRANSITIONAL CELL CARCINOMA; UNIVARIATE ANALYSIS;

CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RISK FACTORS; SELF REPORT; THAILAND;

EID: 84859717358     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03298.x     Document Type: Article

References (27)

1. Kaunitz AM,. Injectable contraception: the USA perspective IPPF Med Bull 1992; 26: 1-3.
2. Liskin L, Blackburn R,. Hormonal contraception: new long-acting methods. Popul Rep K 1987; 3: K57-87.
3. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, et al., Carcinoma of the ovary. J Epidemiol Biostat 2001; 6: 107-38.
4. Sriplung H, Sontipong S, Martin N, Wiangnon S, Vootiprux V, Cheirsilpa A, et al., Cancer in Thailand. Vol.III, 1995-1997. In:, Sriplung H, Sontipong S, Martin N, et al., (Eds). Cancer in Thailand. Ministry of public health, Ministry of University Affairs, National Cancer Institute Report. Bangkok: Medical Publisher; 2004. pp. 1-161.
5. Ramathibodi Cancer Registry. Annual report 1990-2001. Bangkook, Thailand: Ramathibodi Hospital, Mahidol University, 1-20.
6. Benjapibal MVP,. Primary epithelial cancer and malignant germ cell tumor of ovary: A review of 368 cases. Thai J Obstet Gynaecol 2001; 13: 23-8.
7. Benjapibal MSI, Boriboonhiransarn D, Vichaidith P, Netphisuth A, Singto N,. Primary ovarian tumors in postmenopausal women: a 10-year review. Siriraj Hosp Gaz 2000; 52: 307-12.
8. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al., Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int J Cancer 1995; 62: 678-84.
9. Hildreth NG, Kelsey JL, LiVolsi VA, Fischer DB, Holford TR, Mostow ED, et al., An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114: 398-405.
10. Rosenberg L, Shapiro S, Slone D, Kaufman DW, Helmrich SP, Miettinen OS, et al., Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982; 247: 3210-2.
11. Oral contraceptive use and the risk of ovarian cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983; 249: 1596-9.
12. Risch HA,. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997; 89: 1726-7.
13. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1991; 49: 191-5.
14. Narkavonnakit T, Bennett T, Balakrishnan TR,. Continuation of injectable contraceptives in Thailand. Stud Fam Plann 1982; 13: 99-105.
15. Taneepanichskul S, Reinprayoon D, Phaosavadi S,. DMPA use above the age of 35 in Thai women. Contraception 2000; 61: 281-2.
16. Olaitan A, Mocroft A, Jacobs I,. Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996. BJOG 2000; 107: 1094-6.
17. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. SEER Cancer Statistics Review, 1975-2008, Bethesda, MD: National Cancer Institute, Bethesda, MD, USA. Available from:, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
18. Srivatanakul P,. Ovarian cancer. In:, Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P, editors. Cancer in Thailand 1998-2000, Vol. IV, 1st edn. Bangkok: Bangkok Medical Publisher; 2007. pp. 51-3.
19. Attasara P, Srivatanakul P, Sriplung H,. cancer incidence in Thailand. In:, Khuhaprema T, Srivatanakul P, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y, editors. Cancer in Thailand 2001-2003, Vol. V, 1st edn. Bangkok: Bangkok Medical Publisher; 2010. pp. 3-76.
20. Risch HA,. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998; 90: 1774-86.
21. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL, et al., A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994; 139: 654-61.
22. Beral V, Doll R, Hermon C, Peto R, Reeves G,. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 303-14.
23. Lumbiganon P,. Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary. Contraception 1994; 49: 203-9.
24. Nanda K, Morrison CS, Kwok C, Byamugisha J, Jones L, Sriplienchan S, et al., Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand. Contraception 2011; 83: 542-8.
25. Jordan SJ, Siskind V, C Green A, Whiteman DC, Webb PM,. Breastfeeding and risk of epithelial ovarian cancer. Cancer Causes Control 2010; 21: 109-16.
26. Titus-Ernstoff L, Rees JR, Terry KL, Cramer DW,. Breast-feeding the last born child and risk of ovarian cancer. Cancer Causes Control 2010; 21: 201-7.
27. Jordan SJ, Whiteman DC, Purdie DM, Green AC, Webb PM,. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006; 103: 1122-9.